Project Number GC-2013554 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2017 View Full Project Details for Phase 1 Studies and preparation of clinical phase 2 IND of MW150 : Novel Stress Kinase Inhibitor Candidate Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) f. Inflammation Researcher and Organization Principal Investigator WINDISCH, MANFRED Principal Investigator First Name MANFRED Principal Investigator Last Name WINDISCH Awardee Organization Neurokine Therapeutics Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement Program to Accelerate Clinical Trials (PACT) RFP FY Overall Cost $1,688,985 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
